Media Relations

Posted on: 06-27-2011 Posted in: Press Releases

Medical and Dental practitioners have realized how prevalent and consuming sleep problems can be for their patients. Unfortunately most treatments are expensive and/or require invasive surgery.

Recognizing a real need the aveoTSD was developed to provide patients a simple device that effectively deals with excesssive snoring, and helps prevent the health problems that arise from sleep disordered breathing (snoring and obstructive sleep apnea)

• Snoring is a major cause of relationship breakdown
• Snoring, in itself, can cause hypertension and is a leading
indicator for Obstructive Sleep Apnea
• OSA is now seen as a primary cause of heart disease,
depression, diabetes, fatigue, loss of concentration, car accidents,
anxiety and aggression.

Over 20% of the population, men, women and children have OSA,
but 95% have not been diagnosed.

Treatment Comparisons:

CPAP – a machine that forces air through a mask while the patient sleeps. Cost – $1000+, with following costs for masks and filters. CPAP has less than a 45% compliance rate – cpap is uncomfortable, hard to transport and requires power.

Dental Implants – Mandibular Advancment Devices, the idea being to slowly advance the jaw over time, bringing the tongue forward to open the airway. Cost – $1600+, with followup. MAD’s are shown to work but have been shown to cause pain and problems with the jaw.

Surgery – There are numerous surgical procedures to solve snoring and OSA. The Pillar Procedure sets 3 tension pillars into the soft palate, other procedures are designed to reduce obstruction of the airway. Cost – $1500 – $10 000+. Invasive, painful, non corrective and efficacy is inconclusive.

There is no single treatment or device that will solve snoring and OSA for every patient. The goal is efficacy – how effective the treatment is for the majority; and compliance – do patients use the treatment to gain full effect.

At a cost of $150 US, the aveoTSD is a simple, effective and compliant device. It costs far less than all other common treatments, it has been clinically studied (FDA and Health Canada compliant)

The aveoTSD is marketed and sold through Ethics International. The philosophy of Ethics International is to provide cost effective, proven and innovative products to improve health, personal wellbeing, communities and the business/consumer relationship.

The aveoTSD is a perfect match for the fundamental goal of Ethics International and the obvious needs of 20% of the population who suffer from sleep disorders and problem snoring. This simple, effective and proven device provides relief to sufferers, and their partners.

Revenue from sales of the aveoTSD are used to fund a variety of projects that support community well-being through fostering self-determination. We encourage media interest to promote our business ethic, the products, and the projects we sponsor.

If you wish an interview, or further material from Ethics International please contact us.